共有 50 笔近期内部人交易记录记录，涉及 Johnson & Johnson (JNJ), 包括 17 笔买入 和 33 笔卖出. 内部人买入总额为 $257.69K 内部人卖出总额为 $31.34M.
近期活跃的重要内部人包括 Hewson Marillyn A, Pinto Daniel E, Woods Eugene A.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — JNJ
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-10 |
Hewson Marillyn A |
Director |
限制性股票授予 (RSU) |
206 |
- |
- |
14,513 |
| 2026-03-10 |
Pinto Daniel E |
Director |
限制性股票授予 (RSU) |
129 |
- |
- |
462 |
| 2026-03-10 |
Woods Eugene A. |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
5,240 |
| 2026-02-27 |
Decker Robert J |
VP Corporate Controller |
期权行权（卖出） |
4,075 |
$115.67 |
$471.36K |
- |
| 2026-02-20 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
知情卖出 |
1,322 |
$245.66 |
$324.76K |
25,447 |
| 2026-02-18 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
期权行权（卖出） |
13,625 |
$115.67 |
$1.58M |
- |
| 2026-02-17 |
Reed John C |
EVP, Innovative Medicine, R&d |
知情卖出 |
2,283 |
$243.00 |
$554.77K |
10,658 |
| 2026-02-17 |
Wolk Joseph J |
Exec VP, CFO |
期权行权（卖出） |
19,241 |
$115.67 |
$2.23M |
- |
| 2026-02-17 |
Swanson James D. |
EVP, CIO |
期权行权（卖出） |
20,521 |
$164.62 |
$3.38M |
- |
| 2026-02-17 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
知情卖出 |
6,197 |
$243.39 |
$1.51M |
23,003 |
| 2026-02-15 |
Reed John C |
EVP, Innovative Medicine, R&d |
期权行权（卖出） |
1,349 |
- |
- |
1,349 |
| 2026-02-15 |
Duato Joaquin |
CEO and Chairman of the Board |
期权行权（卖出） |
3,682 |
- |
- |
3,682 |
| 2026-02-15 |
Wolk Joseph J |
Exec VP, CFO |
期权行权（卖出） |
1,971 |
- |
- |
1,971 |
| 2026-02-15 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
期权行权（卖出） |
1,594 |
- |
- |
1,594 |
| 2026-02-15 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
期权行权（卖出） |
606 |
- |
- |
606 |
| 2026-02-15 |
Decker Robert J |
VP Corporate Controller |
期权行权（卖出） |
339 |
- |
- |
338 |
| 2026-02-15 |
Swanson James D. |
EVP, CIO |
期权行权（卖出） |
492 |
- |
- |
491 |
| 2026-02-15 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
期权行权（卖出） |
492 |
- |
- |
491 |
| 2026-02-15 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
期权行权（卖出） |
961 |
- |
- |
961 |
| 2026-02-15 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
期权行权（卖出） |
1,028 |
- |
- |
1,028 |
| 2026-02-15 |
Mulholland Kristen |
EVP, Chief HR Officer |
期权行权（卖出） |
419 |
- |
- |
418 |
| 2026-02-13 |
Duato Joaquin |
CEO and Chairman of the Board |
期权行权（卖出） |
73,054 |
- |
- |
- |
| 2026-02-13 |
Wolk Joseph J |
Exec VP, CFO |
期权行权（卖出） |
37,463 |
- |
- |
- |
| 2026-02-13 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
期权行权（卖出） |
1,302 |
- |
- |
- |
| 2026-02-13 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
期权行权（卖出） |
13,706 |
- |
- |
- |
| 2026-02-13 |
Decker Robert J |
VP Corporate Controller |
期权行权（卖出） |
312 |
- |
- |
- |
| 2026-02-13 |
Swanson James D. |
EVP, CIO |
期权行权（卖出） |
19,368 |
$165.89 |
$3.21M |
- |
| 2026-02-13 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
期权行权（卖出） |
408 |
- |
- |
- |
| 2026-02-13 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
期权行权（卖出） |
651 |
- |
- |
- |
| 2026-02-13 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
期权行权（卖出） |
4,378 |
- |
- |
- |
| 2026-02-13 |
Mulholland Kristen |
EVP, Chief HR Officer |
期权行权（卖出） |
410 |
- |
- |
- |
| 2026-02-09 |
Duato Joaquin |
CEO and Chairman of the Board |
限制性股票授予 (RSU) |
73,054 |
- |
- |
73,054 |
| 2026-02-09 |
Wolk Joseph J |
Exec VP, CFO |
限制性股票授予 (RSU) |
37,463 |
- |
- |
37,463 |
| 2026-02-09 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
限制性股票授予 (RSU) |
27,412 |
- |
- |
27,412 |
| 2026-02-09 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
限制性股票授予 (RSU) |
13,706 |
- |
- |
13,706 |
| 2026-02-09 |
Decker Robert J |
VP Corporate Controller |
限制性股票授予 (RSU) |
2,741 |
- |
- |
2,741 |
| 2026-02-09 |
Swanson James D. |
EVP, CIO |
限制性股票授予 (RSU) |
9,412 |
- |
- |
9,412 |
| 2026-02-09 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
限制性股票授予 (RSU) |
8,594 |
- |
- |
8,594 |
| 2026-02-09 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
限制性股票授予 (RSU) |
13,706 |
- |
- |
13,706 |
| 2026-02-09 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
限制性股票授予 (RSU) |
4,378 |
- |
- |
4,378 |
| 2026-02-09 |
Mulholland Kristen |
EVP, Chief HR Officer |
限制性股票授予 (RSU) |
3,602 |
- |
- |
3,602 |
| 2026-02-06 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
期权行权（卖出） |
38,945 |
$101.87 |
$3.97M |
- |
| 2026-02-06 |
Mulholland Kristen |
EVP, Chief HR Officer |
期权行权（卖出） |
5,625 |
$101.87 |
$573.02K |
- |
| 2026-02-06 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
期权行权（卖出） |
15,571 |
$101.87 |
$1.59M |
- |
| 2026-02-05 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
期权行权（卖出） |
8,921 |
$129.51 |
$1.16M |
- |
| 2026-01-26 |
Duato Joaquin |
CEO and Chairman of the Board |
知情卖出 |
48,782 |
$221.48 |
$10.8M |
30,852 |
| 2025-12-09 |
Hewson Marillyn A |
Director |
限制性股票授予 (RSU) |
247 |
- |
- |
14,153 |
| 2025-12-09 |
Pinto Daniel E |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
331 |
| 2025-12-09 |
Woods Eugene A. |
Director |
限制性股票授予 (RSU) |
186 |
- |
- |
5,058 |
| 2025-11-26 |
Morikis John G |
Director |
知情买入 |
1,250 |
$206.15 |
$257.69K |
1,849 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
